Case studies

Delivered work. Specific sponsors.

Each case study is a working analytical deployment — not a marketing one-pager. The flagship pembro+lenva safety report is live and reviewable. The 4DMT capsid integration, reprogramming intelligence study, and pembro+lenva efficacy companion are gated to verified clinicians and sponsors. Active and pre-registered indication studies (MS, HTN, Anxiety, Autism, PD, etc.) have moved to the Pipeline.

→
Moved to Pipeline: the MS RRMS study and the HTN + Atherosclerosis combined protocol now live with the other 21 active indication studies. View pipeline →

Adjacent deployment.

Want a deeper case-study walkthrough?

Verified clinicians and sponsors unlock the full manuscript and KOL deck for each case study. Briefings can focus on any single case.

Contact Us →